GC
TARO

Globeflex Capital’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

Globeflex Capital’s Portfolio TARO Stock Details TARO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-72,459
Closed -$7.12M – 459
2018
Q3 		$7.12M Buy
+72,459
New +$7.84M 1.4% 3

Other funds holding TARO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $40.7B AUM 39.97% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
AL
AJO LP Philadelphia, Pennsylvania $199M AUM 109.68% 1-Year Est. Return
FCH
Freestone Capital Holdings Seattle, Washington $3.86B AUM 26.3% 1-Year Est. Return

Globeflex Capital's TARO Position: Q4 2018 in Review

Globeflex Capital sold out of Taro Pharmaceutical Industries Ltd. (TARO) in Q4 2018, closing a stake of 72,459 shares — an estimated $7.12M sold.

Globeflex Capital first reported a position in TARO in Q3 2018 and held it in 1 quarter. The position peaked at $7.12M in Q3 2018. 94 funds tracked by Wall St. Rank hold TARO as of Q4 2018.

  • Globeflex Capital reported no remaining Taro Pharmaceutical Industries Ltd. position as of Q4 2018 after selling out during the quarter.
  • Globeflex Capital sold 72,459 Taro Pharmaceutical Industries Ltd. shares in Q4 2018, an estimated $7.12M.
  • Globeflex Capital first reported a position in Taro Pharmaceutical Industries Ltd. in Q3 2018 and held it in 1 quarter.
  • Globeflex Capital's Taro Pharmaceutical Industries Ltd. position peaked at $7.12M in Q3 2018.
  • 94 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q4 2018.

Based on Globeflex Capital's 13F filing for Q4 2018, filed 14 Feb 2019.